View in EDS

Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer.
Authors: Gao Y; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Li LX; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Rowland A; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Karapetis CS; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia., Parent N; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Kichenadasse G; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia., Hopkins AM; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Sorich MJ; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia. Electronic address: michael.sorich@flinders.edu.au.
Source: Cancer letters [Cancer Lett] 2026 Feb 28; Vol. 639, pp. 218191. Date of Electronic Publication: 2025 Dec 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1872-7980
DOI:10.1016/j.canlet.2025.218191